Needle gauges and syringe sizes: what the labels specify

The gauges approved labels actually name

How to read the table: each row is a specification one label gives for its own product, taken from the instructions for use or the how-supplied section. Nothing crosses between rows.

The widest and the narrowest: the widest needle on this table is the intramuscular depot needle and the narrowest is a pen needle for a clear solution. No label in this set gives a reason for the diameter it names, so the gap is reported here and not explained; the route page sets out what these same documents do say about route and preparation.

What these documents do with the two jobs: they separate them. Egrifta SV is the clearest case, specifying a full inch of 20-gauge tubing for its mixing step and half an inch of 30-gauge for its injection step, and no label in this set asks one needle to do both.

What the labels say about syringe size

The tirzepatide vial line: the Mounjaro label states that a syringe appropriate for dose administration is used, giving a 1mL syringe capable of measuring a 0.5mL or 0.6mL dose as its example, with a new syringe and needle for each injection.

Why those two volumes: the same label reports each single-dose pen or vial as 0.5mL of solution, and each multi-dose presentation as 2.4mL delivering four doses of 0.6mL. The syringe spec is downstream of the fill volume.

The insulin scale, which is a different animal: Humalog is supplied as U-100 and U-200, and its label states that no dose conversion is performed with the prefilled pens because the dose window already shows insulin units.

Where the scale is easy to misread: an insulin unit is a unit of biological activity, not a fixed volume, so the volume holding one unit depends on the concentration. U-100 puts 100 units in a milliliter and U-40 puts 40 in the same milliliter, so one unit of the second occupies 2.5x the volume of one unit of the first, which is 100 divided by 40 and nothing more. Our U-100 vs U-40 page works the same arithmetic through in full.

What does the gauge number on a needle mean?

It designates the outer diameter of the needle tubing, under a scale where the number rises as the tube gets thinner. ISO 9626, second edition, published 2016, sets the size designation and dimensions for stainless steel medical needle tubing, by nominal outer diameter, the corresponding gauge, and wall thickness, across gauges from 10 down to 34.

The practical read: a 32G pen needle is far finer than a 19 gauge depot needle, even though 32 is the larger number. The standard states the inversion without explaining where it came from, so no origin story for it appears here either.

What it excludes: length, wall thickness and bevel. Labels that care about those state them separately, which is why Egrifta SV writes both a gauge and an inch measurement for each of its two needles.

Which needle gauges do approved labels specify?

Across the documents on this page, from 19 to 32. The intramuscular depot sits at the wide end, the vial-and-syringe products sit in the middle at 20 for mixing and 30 for injecting, and the pens sit at the narrow end at 29 through 32.

The pen figures, precisely: the Ozempic multi-dose pens and the Wegovy FlexTouch pen ship a 32G 4mm needle and name compatible needles up to 8mm. Neither label carries those figures for its single-dose presentations. Genotropin lists a 29G, 30G or 31G pen needle. Norditropin states compatibility with disposable needles up to 8mm long.

What no label in this set does: publish a gauge recommendation for a product other than its own, or for a compound that has no approved label at all.

Why do some labels specify needle length as well as gauge?

Because the target tissue sits at a depth, and gauge says nothing about depth. The pen labels that state a length work in millimeters and the gluteal depot works in inches, at 1.5 inches supplied. Genotropin is the one document in the table that names gauges and no length at all.

The one stated rationale: Sandostatin LAR Depot names a 2 inch 19 gauge needle, not supplied in the kit, for patients with greater skin to muscle depth. That is the only depth rationale any label in this set prints.

The non-injecting length: the Egrifta SV mixing needle is a full inch and its injection needle is half that. The label attaches a step to each, "used for mixing" and "used for injection", and prints no reason for either length.

What syringe size do the labels specify?

Where a product ships in a vial, the answer is small and stated: Egrifta SV supplies 1mL syringes, and the Mounjaro label gives a 1mL syringe capable of measuring 0.5mL or 0.6mL as its worked example. Both documents state that a new syringe and needle are used each time.

Where the product is a prefilled pen: no separate user-filled syringe is involved. The dose window on a Humalog pen shows insulin units directly and its label states that no conversion is performed.

Why the barrel matters at all: a barrel is a ruler, and reading it correctly depends on knowing which scale it carries. Our unit page takes that apart mark by mark.

Why does one kit ship a mixing needle and an injection needle?

The label does not say why. What it does is name a step for each: the Egrifta SV injection box is listed with 60 one-inch 20-gauge needles "used for mixing" and 30 half-inch 30-gauge needles "used for injection", and the steps that follow put the wide one on the sterile water and the fine one on the person.

What the label does with the mixing needles: uses two, and discards both. The first sits on a fresh 1mL syringe and moves sterile water into the vial. The second sits on a second fresh syringe and withdraws the mixed solution. The 30-gauge injection needle goes on only after that.

The counting detail: two mixing needles per dose against one injection needle, which is why the 30-day box holds 60 of one and 30 of the other, alongside 60 sterile 1mL syringes.

The reconstitution note printed in the same section of that label: the water runs down the inside wall of the vial rather than onto the powder, because of foaming. Our reconstitution volume page covers what the water choice does to the arithmetic afterwards.

More from the library

Next to this one: four further pages, covering the documents and the arithmetic on either side of the hardware.

• Subcutaneous vs intramuscular: the route line and the exclusion line in each label, read beside the gauge figures above.
• Injection sites in the trials: the regions the protocols named, beside the hardware that went with them.
• What is a unit: the barrel mark itself, where it came from and what it does not report.
• Units to mg converter: vial, water and scale in, syringe units out, no dose suggested.

Once a week: one specification read of this kind goes out in the weekly briefing, free.

Sources

What this page is built from: one international standard and eight prescribing information documents, each cited for the hardware it specifies for its own product.

What changed on 30 July 2026: a citation audit found two sentences supplying a rationale the Egrifta SV label does not print, and no reference was added or removed to fix either. The label states which needle is used for mixing and which for injection, and it gives no engineering reason for a length or a diameter. Both sentences now report the assignment and say plainly that the reason is absent, which matches what this page already says about the table as a whole.

The standard: the full sourcing and citation-verification standard for this site, including who checks a page before it ships, lives on the methodology page.

Last reviewed: 27 July 2026.

1. 1

   Ozempic (semaglutide) injection, for subcutaneous use. Prescribing information, Novo Nordisk. Instructions for Use and section 16. DailyMed SPL, set id adec4fd2-6858-4c99-91d4-531f5f2a2d79.

2. 2

   Wegovy (semaglutide) injection, for subcutaneous use. Prescribing information, Novo Nordisk. Instructions for Use and section 16. DailyMed SPL, set id ee06186f-2aa3-4990-a760-757579d8f77b.

3. 3

   Genotropin (somatropin) for injection, for subcutaneous use. Prescribing information, Pfizer. Instructions for Use, Genotropin Pen 5. DailyMed SPL, set id ffebf88b-d257-4542-9808-74d9b7167765.

4. 4

   Norditropin (somatropin) injection, for subcutaneous use. Prescribing information, Novo Nordisk. Instructions for Use, FlexPro pen. DailyMed SPL, set id 1058e17c-9261-459c-a3e6-fae38d196c14.

5. 5

   Egrifta SV (tesamorelin) for injection, for subcutaneous use. Prescribing information, Theratechnologies. Section 16 and Instructions for Use. DailyMed SPL, set id 3d783378-b02d-4f19-99dd-0fc91a042224.

6. 6

   Sandostatin LAR Depot (octreotide acetate) for injectable suspension, for gluteal intramuscular use. Prescribing information, Novartis. Sections 2 and 16. DailyMed SPL, set id d0b7fe9e-7000-4b79-ba3b-291ce92c14f9.

7. 7

   Mounjaro (tirzepatide) injection, for subcutaneous use. Prescribing information, Eli Lilly and Company. Sections 2.2, 11, 16, and Instructions for Use. DailyMed SPL, set id d2d7da5d-ad07-4228-955f-cf7e355c8cc0.

8. 8

   Humalog (insulin lispro) injection, for subcutaneous or intravenous use. Prescribing information, Eli Lilly and Company. Sections 2.1, 2.2, 2.3, and 3. DailyMed SPL, set id c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f.

9. 9

   International Organization for Standardization. ISO 9626:2016, Stainless steel needle tubing for the manufacture of medical devices: requirements and test methods. Second edition, 2016-08-01. Clauses 5.5 and 5.6. iso.org/standard/60480.html.